Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
,
In animal models, it has been shown preclinically to upregulate growth hormone receptors in tendon fibroblasts, stimulate angiogenesis via the VEGFR2/Akt-eNOS pathway, and modulate nitric oxide signaling, mechanisms that, if they translate to humans, could support tissue repair in a hormonal environment where estrogen-dependent healing capacity is declining
Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer
Ascendis is headquartered in Copenhagen, Denmark and has additional facilities in Europe and the United States
US$ 29.43
US$ 25.94
US$ 20.72
US$ 27.81
